Author: Slate Podcasts

When you settle in to watch the Presidential debate tonight, maybe you’ll be listening to hear how Trump talks about the New York Times story regarding his tax returns. Maybe you’ll want to hear what Joe Biden has to say about the Supreme Court. 

But Rick Hasen, an election law expert at UC-Irvine, says he’ll be listening for something else: how the two candidates talk about the integrity of this election.

Guest: Rick Hasen, an election law expert at UC-Irvine and the author of “Election Meltdown: Dirty Tricks, Distrust, and the Threat to American Democracy.”

Slate Plus members get bonus segments and ad-free podcast feeds. Sign up now.

---

Hosted on Acast. See acast.com/privacy for more information.

Over the weekend, President Trump announced that Amy Coney Barrett would be his pick to replace Justice Ruth Bader Ginsburg on the Supreme Court. What can we glean from her biography and past rulings about what kind of Justice she would be? 

Guest: Mark Joseph Stern, covers the courts and the law for Slate.

Slate Plus members get bonus segments and ad-free podcast feeds. Sign up now.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Over the weekend, President Trump announced that Amy Coney Barrett would be his pick to replace Justice Ruth Bader Ginsburg on the Supreme Court. What can we glean from her biography and past rulings about what kind of Justice she would be? 

Guest: Mark Joseph Stern, covers the courts and the law for Slate.

Slate Plus members get bonus segments and ad-free podcast feeds. Sign up now.

---

Hosted on Acast. See acast.com/privacy for more information.

As of Sept. 24, there are 42 vaccines in clinical trials on humans. At least 92 others are being developed but have not yet gone to trial. For months, the world has tracked the progression of these vaccines closely, with the expectation that once one arrives on the market, we can finally start to go back to normal. But, is that true? Does the world really look much different with an effective vaccine?

Guest: Dr. Paul Offit, professor of pediatrics at the Children's Hospital of Philadelphia.

Host

Celeste Headlee

 

Learn more about your ad choices. Visit megaphone.fm/adchoices

As of Sept. 24, there are 42 vaccines in clinical trials on humans. At least 92 others are being developed but have not yet gone to trial. For months, the world has tracked the progression of these vaccines closely, with the expectation that once one arrives on the market, we can finally start to go back to normal. But, is that true? Does the world really look much different with an effective vaccine?

Guest: Dr. Paul Offit, professor of pediatrics at the Children's Hospital of Philadelphia.

Host

Celeste Headlee

 

---

Hosted on Acast. See acast.com/privacy for more information.

As of Sept. 24, there are 42 vaccines in clinical trials on humans. At least 92 others are being developed but have not yet gone to trial. For months, the world has tracked the progression of these vaccines closely, with the expectation that once one arrives on the market, we can finally start to go back to normal. But, is that true? Does the world really look much different with an effective vaccine?

Guest: Dr. Paul Offit, professor of pediatrics at the Children's Hospital of Philadelphia.

Host

Celeste Headlee

 

---

Hosted on Acast. See acast.com/privacy for more information.